SEC Form D · filed May 1, 2020
NovaBay Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
Paul E. Freiman · EMERYVILLE, CADirectorYenyou (Jeff) E. Zheng · EMERYVILLE, CADirectorMijia (Bob) E. Wu · EMERYVILLE, CADirectorSwan E. Sit · EMERYVILLE, CADirectorXiaopei (Ray) Wang · EMERYVILLE, CADirectorXinzhou (Paul) E. Li · EMERYVILLE, CADirectorJustin Hall · EMERYVILLE, OHExecMatt Forti · Highland Park, ILDirectorCato Partners GP, LLC · New York, NYDirectorJp A. Paquin · New York, NYDirectorCato Partners Management, LLC · New York, NYDirectorSamuel Schreiber · Chilmark, MADirectorBrook Katzen · Chilmark, MADirectorLynn Christopher · EMERYVILLE, CAExecDavid Irwin · Bellevue, WADirectorSteven M. Diedrich · Waco, TXDirectorBrian Moreland · Bronx, NYDirectorJerry L. Whitmire · Tempe, AZDirectorvan Biema Value Partners, LLC · New York, NYDirectorStephen Dalby · Lehi, UTDirectorLynn Christopher · EMERYVILLE, CAExecJustin Hall · EMERYVILLE, OHExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗